Combination of Exchange Transfusion Treatment and Hydroxyurea Cause Beneficial Changes to Laboratory Parameters and Clinical Outcome in Patients with Sickle Cell Disease/β Thalassemia Compared with Hydroxyurea or Exchange Transfusion Alone
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.